Cargando…

Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma

BACKGROUND: In patients with metastatic melanoma, central nervous system (CNS) involvement is associated with poor prognosis, increased costs, and higher health care resource utilization (HCRU); however, previous cost-estimate studies were conducted before widespread use of targeted therapies and im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tawbi, Hussein, Bartley, Karen, Seetasith, Arpamas, Kent, Matthew, Lee, Janet, Burton, Elizabeth, Haydu, Lauren, McKenna, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372958/ https://www.ncbi.nlm.nih.gov/pubmed/35199578 http://dx.doi.org/10.18553/jmcp.2022.28.3.342

Ejemplares similares

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study
por: Tawbi, Hussein, et al.
Publicado: (2021)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
por: Ogata, Dai, et al.
Publicado: (2021)

OTHR-08. PREDICTION OF RISK OF CENTRAL NERVOUS SYSTEM METASTASIS FOR AJCC 8(TH) EDITION STAGE III MELANOMA PATIENTS
por: Haydu, Lauren, et al.
Publicado: (2019)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
por: Sadetsky, Natalia, et al.
Publicado: (2020)

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
por: Karz, Alcida, et al.
Publicado: (2022)

SDPS-37 IDENTIFICATION OF TIME-COURSE RELATED, TREATMENT-RELATED, AND PATIENT-RELATED PROGNOSTIC FACTORS IN BRAF-MUTANT MELANOMA BRAIN METASTASES.
por: Erickson, Lily G, et al.
Publicado: (2023)

919. Household Flu Transmission and Healthcare Resource Use among Patients Treated with Baloxavir versus Oseltamivir for Influenza: An Outpatient Prospective Survey in the United States
por: Best, Jennie H, et al.
Publicado: (2023)

Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
por: Wong, William Bruce, et al.
Publicado: (2023)

Economic burden of toxicities associated with treating metastatic melanoma in eight countries
por: Wehler, Elizabeth, et al.
Publicado: (2015)

Targeted therapy in melanoma
por: Tawbi, Hussein, et al.
Publicado: (2009)

Emergent immunotherapy approaches for brain metastases
por: Wang, Jianbo, et al.
Publicado: (2021)

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
por: Fox, David, et al.
Publicado: (2022)

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases
por: Hasanov, Merve, et al.
Publicado: (2022)

Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016‐2019
por: Neuberger, Edward E., et al.
Publicado: (2022)

Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases – the first Australian experience
por: Awad, Raef, et al.
Publicado: (2013)

Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice
por: Augustyn, Kourtney, et al.
Publicado: (2023)

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020)

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
por: Du, Samuel, et al.
Publicado: (2015)

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
por: Holbrook, Kourtney, et al.
Publicado: (2019)

Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature
por: Piña, Yolanda, et al.
Publicado: (2021)

Multiple metastases in central nervous system and subdural hematoma in the course of melanoma
por: Woźniak-Dąbrowska, Kamila, et al.
Publicado: (2022)

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker
por: Fischer, Grant M., et al.
Publicado: (2020)

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
por: Kreidieh, Firas Y., et al.
Publicado: (2023)

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma
por: Ostovan, Vahid Reza
Publicado: (2012)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Aggregate economic analysis /
por: McKenna, Joseph P., 1922-
Publicado: (1972)

Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma
por: Menzies, Alexander M., et al.
Publicado: (2014)

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
por: Kaufman, Kimberley L., et al.
Publicado: (2014)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
por: Fogarty, Gerald B, et al.
Publicado: (2014)

Resource use and economic burden of eye injuries in Southern Finland
por: Sahraravand, Ahmad, et al.
Publicado: (2021)

Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data
por: Wolf, Douglas C, et al.
Publicado: (2018)

Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases
por: Wesslau, Hanna, et al.
Publicado: (2022)

Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review
por: Tan, Xiang-Lin, et al.
Publicado: (2022)

Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US
por: Kalilani, Linda, et al.
Publicado: (2019)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
por: Seifert, Heike, et al.
Publicado: (2015)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fp4qk7roa318n31830d4jetjma